CohBar, Inc. Completes Cross Border Initial Public Offering

January 07, 2015

CohBar Inc. (TSX-V: COB.U)  (the “Company”), a US-based biotech company, completed a cross border initial public offering on January 6, 2015 of a total of 11,250,000 units (“Units”) at a price of US$1.00 per Unit for gross proceeds of US$11.25 million (the “Offering”). The Offering was conducted on an agency basis by Haywood Securities Inc. Each Unit consisted of one common share and one half of one common share purchase warrant, with each whole warrant entitling the holder to acquire one common share at an exercise price of US$2.00 per share until January 6, 2017.

In connection with the Offering, the Company concurrently filed both a Canadian prospectus and a registration statement on Form S-1 with the United States Securities and Exchange Commission.

Wildeboer Dellelce LLP acted as Canadian counsel to Haywood Securities with a team that included Robert Fonn, Jeff Hergott and Luigi Valente (corporate/securities) and Kevin Fritz (tax).